VRTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 8 328.4404 MXN 1.86% Market Closed

Market Cap: Mex$111.5B

V	Vertex Pharmaceuticals Inc BMV:VRTX	US
	Azrieli Group Ltd OTC:AZRGF	IL
	Severn Trent PLC F:SVT	UK
	SK Hynix Inc F:HY9H	KR
U	UPM-Kymmene Oyj XMUN:RPL	FI
	Yara International ASA F:IU20	NO
V	Veeco Instruments Inc SWB:VEO	US

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

47% > 39%

Exceptional Net Margin

35%

Sustainable 3Y Average Net Margin

21%

Declining Net Margin

35% > 35%

Exceptional Free Cash Flow Margin

29%

Strong 3Y Average Free Cash Flow Margin

17%

Declining Free Cash Flow Margin

41% > 29%

Positive ROE

24%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.